A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure
- PMID: 18226766
- DOI: 10.1016/j.cardfail.2007.09.007
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure
Abstract
Objectives: This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure.
Background: It has been hypothesized that treatment with diuretics may worsen renal function as the result of systemic neurohormonal activation and direct renal vascular effects. UF also removes fluid, but its actions on intrarenal hemodynamics, and therefore renal function, are unknown.
Methods: Patients hospitalized for acute decompensated heart failure with an ejection fraction less than 40% and two or more signs of hypervolemia were randomized to receive UF or intravenous diuretics. Urine output, GFR (as measured by iothalamate), and renal plasma flow (as measured by para-aminohippurate) were assessed before fluid removal and after 48 hours.
Results: Nineteen patients (59 +/- 16 years, 68% were male) were randomized to receive UF (n = 9) or intravenous diuretics (n = 10). The change in GFR (-3.4 +/- 7.7 mL/min vs. -3.6 +/- 11.5 mL/min; P = .966), renal plasma flow (26.6 +/- 62.7 mL/min vs. 16.1 +/- 42.0 mL/min; P = .669), and filtration fraction (-6.9 +/- 13.6 mL/min vs. -3.9 +/- 13.6 mL/min; P = .644) after treatment were not significantly different between the UF and furosemide treatment groups, respectively. There was no significant difference in net 48-hour fluid removal between the groups (-3211 +/- 2345 mL for UF and -2725 +/- 2330 mL for furosemide, P = .682). UF removed 3666 +/- 2402 mL. Urine output during 48 hours was significantly greater in the furosemide group (5786 +/- 2587 mL) compared with the UF group (2286 +/- 915 mL, P < .001).
Conclusions: During a 48-hour period, UF did not cause any significant differences in renal hemodynamics compared with the standard treatment of intravenous diuretics.
Comment in
-
Renal function and ultrafiltration.J Card Fail. 2008 Aug;14(6):533-4; author reply 534. doi: 10.1016/j.cardfail.2008.03.005. Epub 2008 May 27. J Card Fail. 2008. PMID: 18672204 No abstract available.
Similar articles
-
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.Am J Cardiol. 2006 Dec 15;98(12):1627-30. doi: 10.1016/j.amjcard.2006.07.044. Epub 2006 Oct 25. Am J Cardiol. 2006. PMID: 17145223
-
Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.J Card Fail. 2010 Mar;16(3):188-93. doi: 10.1016/j.cardfail.2009.11.005. Epub 2010 Jan 6. J Card Fail. 2010. PMID: 20206891 Clinical Trial.
-
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.Am Heart J. 2003 Mar;145(3):459-66. doi: 10.1067/mhj.2003.166. Am Heart J. 2003. PMID: 12660669 Clinical Trial.
-
Ultrafiltration in the management of heart failure.Curr Opin Crit Care. 2008 Oct;14(5):524-30. doi: 10.1097/MCC.0b013e328309a481. Curr Opin Crit Care. 2008. PMID: 18787444 Review.
-
Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):571-4. doi: 10.2459/JCM.0b013e32833d37b9. J Cardiovasc Med (Hagerstown). 2010. PMID: 20588135 Review.
Cited by
-
Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.Heart Fail Rev. 2012 Mar;17(2):313-24. doi: 10.1007/s10741-011-9248-0. Heart Fail Rev. 2012. PMID: 21559880 Review.
-
Acute Kidney Injury in Pediatric Heart Failure.Curr Cardiol Rev. 2016;12(2):121-31. doi: 10.2174/1573403x12666151119165628. Curr Cardiol Rev. 2016. PMID: 26585035 Free PMC article. Review.
-
Isolated ultrafiltration in heart failure patients.Curr Cardiol Rep. 2012 Jun;14(3):254-64. doi: 10.1007/s11886-012-0257-y. Curr Cardiol Rep. 2012. PMID: 22415396 Review.
-
Pharmacological interventions for heart failure in people with chronic kidney disease.Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD012466. doi: 10.1002/14651858.CD012466.pub2. Cochrane Database Syst Rev. 2020. PMID: 32103487 Free PMC article.
-
Emerging therapies for heart failure: renal mechanisms and effects.Heart Fail Rev. 2012 Jan;17(1):1-16. doi: 10.1007/s10741-010-9191-5. Heart Fail Rev. 2012. PMID: 20803357 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical